RNTX - Rein Therapeutics, Inc.

QQQ $ 604.19 $ 6.27 (1.05 %)

DIA $ 462.08 $ 2.39 (0.52 %)

SPY $ 664.68 $ 4.85 (0.74 %)

TLT $ 91.14 $ -0.05 (-0.05 %)

GLD $ 389.03 $ -8.41 (-2.12 %)

Previous Close

$ 1.28

Open

$ 1.28

Bid

$ 1.15 x 220

Ask

$ 1.30 x 1

Day's Range

$ 1.20 - $ 1.29

52 Week Range

$ 1.04 - $ 4.40

Volume

67,088

Average Volume

Market Cap

29.83M

Beta (5Y Monthly)

$ 1.46

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-14-2025	06-30-2025	10-Q
2	05-15-2025	03-31-2025	10-Q
3	04-07-2025	12-31-2024	10-K
4	11-14-2024	09-30-2024	10-Q
5	08-14-2024	06-30-2024	10-Q
6	05-15-2024	03-31-2024	10-Q
7	04-15-2024	12-31-2023	10-K
8	10-13-2023	09-30-2023	10-Q
9	08-11-2023	06-30-2023	10-Q
10	05-08-2023	03-31-2023	10-Q
11	03-20-2023	12-31-2022	10-K
12	11-01-2022	09-30-2022	10-Q
13	08-15-2022	06-30-2022	10-Q
14	05-05-2022	03-31-2022	10-Q
15	03-28-2022	12-31-2021	10-K
16	11-12-2021	09-30-2021	10-Q
17	08-11-2021	06-30-2021	10-Q
18	05-11-2021	03-31-2021	10-Q
19	03-24-2021	12-31-2020	10-K
20	11-12-2020	09-30-2020	10-Q
21	08-05-2020	06-30-2020	10-Q
22	05-11-2020	03-31-2020	10-Q
23	03-30-2020	12-31-2019	10-K
24	11-07-2019	09-30-2019	10-Q
25	08-06-2019	06-30-2019	10-Q
26	05-08-2019	03-31-2019	10-Q
27	03-29-2019	12-31-2018	10-K
28	11-07-2018	09-30-2018	10-Q
29	08-07-2018	06-30-2018	10-Q
30	05-09-2018	03-31-2018	10-Q
31	04-02-2018	12-31-2017	10-K
32	11-09-2017	09-30-2017	10-Q
33	08-10-2017	06-30-2017	10-Q
34	02-14-2013	12-31-2012	10-Q
35	11-14-2012	09-30-2012	10-Q
36	08-13-2012	06-30-2012	10-Q
37	06-22-2012	03-31-2012	10-K
38	02-14-2012	12-31-2011	10-Q
39	11-14-2011	09-30-2011	10-Q
40	08-12-2011	06-30-2011	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Rein Therapeutics Receives Authorization F...
10/09/2025 11:32:34

Rein Therapeutics Announced FDA Feedback O...
09/22/2025 12:07:23

HC Wainwright & Co. Initiates Coverage On ...
09/22/2025 10:14:53

HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Rein Therapeutics (NASDAQ:RNTX) with a Buy rating and a...

Rein Highlights Translational Data Demonst...
09/17/2025 11:43:27

12 Health Care Stocks Moving In Thursday's...
09/04/2025 17:05:59

Rein Therapeutics Files Prospectus Related...
09/03/2025 21:17:42

-SEC Filing

12 Health Care Stocks Moving In Thursday's...
08/28/2025 21:06:27

Brookline Capital Downgrades Rein Therapeu...
08/19/2025 14:17:54

Brookline Capital analyst Kemp Dolliver downgrades Rein Therapeutics (NASDAQ:RNTX) from Buy to Hold.

UK MHRA Authorizes Rein Therapeutics To In...
08/19/2025 12:12:14

Rein Therapeutics ("Rein") (NASDAQ:RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medi...

Aileron Therapeutics Q2 EPS $(0.28) Misses...
08/14/2025 20:14:43

Aileron Therapeutics (NASDAQ:RNTX) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate o...

Rein Therapeutics Enters Into Two Strategi...
07/30/2025 12:34:25

Rein Therapeutics ("Rein") (NASDAQ:RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medi...

12 Health Care Stocks Moving In Friday's A...
07/11/2025 21:06:01

12 Health Care Stocks Moving In Friday's P...
06/13/2025 12:11:32

why-rh-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket

Why RH Shares Are Trading Higher By Around...
06/13/2025 09:08:07

12 Health Care Stocks Moving In Thursday's...
06/12/2025 21:06:01

On June 10, 2025, Rein Therapeutics Paused...
06/12/2025 20:32:31

-SEC Filing

On June 10, 2025, Rein Therapeutics Paused...
06/12/2025 20:30:15

-SEC Filing

Rein Therapeutics Doses First Patient in P...
05/27/2025 11:05:39

Rein Therapeutics ("Rein") (NASDAQ:RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medi...

Rein Therapeutics Q1 EPS $(0.25) Misses $(...
05/15/2025 20:21:21

Rein Therapeutics (NASDAQ:RNTX) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $...

Rein Therapeutics Initiates RENEW Phase 2 ...
05/12/2025 11:16:34